ari.org.uk
Home
Questions
Organisations
Topics
Research fields
About the data
Department for Science, Innovation & Technology
Government
UK-wide
Questions from the Department for Science, Innovation & Technology:
Include archived/expired questions
321-340 of 512 results
Building Digital UK - Telecoms market
How would future market consolidation impact connectivity for businesses, public sector organisations and residential premises on different networks? What recommendations should be made to the UK government to prepare for these scenarios?
Department for Science, Innovation & Technology, 2024
telecoms market
connectivity
infrastructure planning
technological innovations
market consolidation
See details
Building Digital UK - Telecoms market
What factors in the market increase the likelihood of future market consolidation and what barriers exist that decrease this likelihood? Why would an actor in the market pursue integration of another firm’s network and why would they not?
Department for Science, Innovation & Technology, 2024
market consolidation
telecoms market
infrastructure planning
See details
Building Digital UK - Telecoms market
To what extent would future market consolidation affect the different actors within the market and the performance of the market as a whole?
Department for Science, Innovation & Technology, 2024
telecoms market
infrastructure planning
market consolidation
See details
Building Digital UK - Telecoms market
To what extent can investment in the market be predicted? What factors incentivise and disincentives investment into a supplier or subcontractor?
Department for Science, Innovation & Technology, 2024
investment
market prediction
supplier
subcontractor
telecoms market
See details
Building Digital UK - Telecoms market
What incentivises and supports sharing of knowledge to promote sector-wide best practice in a competitive market place?
Department for Science, Innovation & Technology, 2024
telecoms market
infrastructure planning
technological innovations
knowledge sharing
See details
Government Office for Life Sciences - Net Zero
Evidence and data on the climate impact of life sciences activity.
Department for Science, Innovation & Technology, 2024
life sciences
climate impact
evidence-based policy
See details
Government Office for Life Sciences - Real estate
Evidence on the impact of the planning system on the cost of establishing manufacturing and R&D activity.
Department for Science, Innovation & Technology, 2024
manufacturing
R&D activity
planning system
economic impact
regulations
See details
Government Office for Life Sciences - Access to Finance
Data on risk-adjusted returns on UK start-ups relative to other countries.
Department for Science, Innovation & Technology, 2024
start-ups
investment
economic indicators
international comparators
finance
See details
Government Office for Life Sciences - Access to Finance
Evidence on the determinants of foreign investment on UK start-ups.
Department for Science, Innovation & Technology, 2024
foreign investment
start-ups
economics
See details
Government Office for Life Sciences - Access to Finance
More comprehensive evidence on the determinants of funding for early-stage companies, and on what stage companies struggle to secure funding the most.
Department for Science, Innovation & Technology, 2024
funding
early-stage companies
investment
business environment
See details
Government Office for Life Sciences - Access to Finance
Data on the number of companies that fail to secure funding in the UK but successfully access capital in the US.
Department for Science, Innovation & Technology, 2024
funding
capital access
investment
economic indicators
international comparison
See details
Government Office for Life Sciences - Skills
Evidence on the gap between the skills required by employers in the sector and those currently provided through various forms of education and training.
Department for Science, Innovation & Technology, 2024
skills gap
education
training
employment
workforce
See details
Government Office for Life Sciences - Skills
Evidence on the skills shortage, including quantitative assessments of the skills gap in terms of numbers of workers for different professions and levels of qualification.
Department for Science, Innovation & Technology, 2024
skills shortage
quantitative assessments
professions
qualification levels
workforce
See details
Government Office for Life Sciences - Skills
Evidence and data on the current composition of the workforce in the sector.
Department for Science, Innovation & Technology, 2024
workforce composition
evidence-based policy
economic indicators
life sciences
employment
See details
Government Office for Life Sciences - Manufacturing activity
Supply chain resilience: more comprehensive evidence on the supply chain relationships between companies in the UK and those in other countries, as well as evidence on the potential impact of supply chain restrictions.
Department for Science, Innovation & Technology, 2024
supply chain
manufacturing
international trade
economics
regulations
See details
Government Office for Life Sciences - Manufacturing activity
Health resilience: More comprehensive data on capacity and capabilities for companies in the sector to better identify areas of concern with respect to supply vulnerabilities.
Department for Science, Innovation & Technology, 2024
health resilience
manufacturing
supply chain
See details
Government Office for Life Sciences - Manufacturing activity
Manufacturing Innovation: We would like to have a more comprehensive forward look for new drugs, devices, or other therapeutics to identify potential innovations faster.
Department for Science, Innovation & Technology, 2024
manufacturing
innovation
healthcare
research and development
See details
Government Office for Life Sciences - Investment - Business environment
We would like to better understand the overall determinants of investment and location decisions, including how board sentiment might override other financial considerations.
Department for Science, Innovation & Technology, 2024
investment
location decisions
board sentiment
business environment
See details
Government Office for Life Sciences - Investment - Business environment
We would further like to understand whether there is any evidence for co-location of R&D and manufacturing activity and whether this depends on the stage of the R&D conducted on site.
Department for Science, Innovation & Technology, 2024
research and development
manufacturing
economic impact
investment
See details
Government Office for Life Sciences - Investment - Business environment
We would like to understand how clinical trial activity is affected by the broader commercial environment and, in particular, price regulation and other cost control measures.
Department for Science, Innovation & Technology, 2024
clinical trials
commercial environment
price regulation
cost control measures
See details
17